How it works - Qlucore Diagnostics

Qlucore Diagnostics platform solution

Qlucore Diagnostics is a scalable diagnostic solution from data to report, with machine learning based subtype classification combined with easy-to-understand reporting and visualization for clear communication between lab, clinicians, and patients.

• AI-powered, disease-specific machine learning classifier models based on gene expression.
• Plug-in software architechture for scalability to mutliple disease areas.
• Tier based gene fusion reporting.
• Patient-friendly visualizations in an easy-to-use and cost-effective software solution. 
• Based on RNA sequencing data and standard NGS workflows.

Acute Lymphoblastic Leukemia (BCP-ALL)

The first application area for the Qlucore Diagnostics platform is RNA-seq based cancer diagnostics in Acute Lymphoblastic Leukemia, including both gene expression subtype classification of B-cell leukemias and gene fusion analysis support. 

Work is ongoing to certify Qlucore Diagnostics for Acute Lymphoblastic Leukemia to comply with the IVDR regulation (CE). 

Informative and customized reports

The output of Qlucore Diagnostics is highly tailored to each disease area. The base is a pdf report that includes conclusions, results, plots, quality metrics and method information. Visualizations are included in the clinical report for better communication between a molecular genetics lab, clinicians and patients.

View a draft example of how a report might look.